LAMEA Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026

The Latin America, Middle East and Africa Cough Syrup Market is expected to witness market growth of 6.7% CAGR during the forecast period (2020-2026).

Cough is the most common symptom of many upper & lower respiratory tract infections. It is also an impulse reaction to functional, chemical, and inflammatory irritation of the tracheobronchial tree that is transmitted by the sensory neurons in the air tract via neurons that exists in the brainstem. Antitussives, which are also called cough suppressants, are majorly utilized to cure the symptoms of cough. This cough suppressant helps in curing cough by decreasing the action of the cough reflex and decrease the urge to cough. The two most common suppressant drugs for cough are Dextromethorphan and Codeine, which are majorly used to cure a cough or related symptoms.

There are many people who use cough syrup to cure different types of cough. It is among the most commonly consumed medication for cough and the common cold. These cough syrups are consumed as a suppressant, reliever, and as mucus thinner by people. However, there are a majority of people who consume these cough syrups when prescribed, but patients also buy this medicine Over the Counter. Not all the medication but some of the cough syrups can have serious side effects or it can have more side effects than its benefits, so its composition makes the medication effective or ineffective.

The Brazil market dominated the LAMEA Online Market by Country in 2019, thereby, achieving a market value of $15.4 million by 2026. The Argentina market is expected to witness a CAGR of 6.8% during (2020 - 2026). Additionally, The UAE market is experiencing a CAGR of 5.4% during (2020 - 2026).

The Cough Suppressants market dominated the Saudi Arabia Cough Syrup Market by Product in 2019, growing at a CAGR of 5.3 % during the forecast period. The Combination Medications market is estimated to grow at a CAGR of 5.3% during (2020 - 2026). Additionally, The Expectorants market is expected to witness highest CAGR of 6.5% during (2020 - 2026).

Based on Product, the market is segmented into Cough Suppressants, Combination Medications and Expectorants. Based on Age Group, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Merck Group, Johnson and Johnson, GlaxoSmithKline PLC (GSK), The Procter and Gamble Company, Reckitt Benckiser Group PLC, Abbott Laboratories, Sanofi S.A., and Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC).

Scope of the Study

Market Segments covered in the Report:

By Product

• Cough Suppressants
• Combination Medications
• Expectorants

By Age Group

• Adult
• Pediatric

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• Pfizer, Inc.
• Novartis AG
• Merck Group
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• The Procter and Gamble Company
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Sanofi S.A.
• Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC)

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free